Shanghai unveils plans for biological medicine industry - (China Daily via NewsPoints Desk)

  • According to a three-year action plan, Shanghai will build high-end manufacturing parks for biological medicine by 2020 to complement and develop interactively with Pudong New Area's Zhangjiang, known as China's pharma valley, China Daily reported Thursday.

  • The parks, which are planned so far in the municipality's districts of Jinshan and Fengxian, as well as Lingang area in Pudong, will focus on medical devices, beauty and biopharmaceuticals respectively, said Cao Hongming, director of the biological medicine division of Shanghai Municipal Science and Technology Commission.

  • Meanwhile, Liu Xinyu, director of the science and technology commission of Jinshan district, said there are 40 enterprises engaged in biological medicine in the district, 14 of which have an annual production value of more than 100 million yuan.

  • "In the future, some projects may carry out research and development in Zhangjiang," Liu added.

  • According to the action plan, Shanghai's goal is that the industry would reach 400 billion yuan in 2020, and applications for 50 drugs and 100 medical devices developed in the city will be made before being marketed by that year.

  • Additionally, the plan said that the city aims to become a biomedical innovation source with industry clusters with international influence by 2025.

Did you like this article?